On January 8, 2026, TD Cowen reduced its price target for Colgate-Palmolive Company (NYSE:CL) from $90 to $86. The firm maintained a Buy rating on the stock. TD Cowen's projection for consumer staples in 2026 included this adjustment. The corporation anticipates a difficult year for large-cap consumer staples, with pricing expected to remain restrained. Volume growth is unlikely to significantly improve from the negative 0.9% reported in 2025.
Separately, on January 7, 2026, Piper Sandler upgraded its price target for Colgate-Palmolive from $82 to $88. The firm also raised its rating from Neutral to Overweight. Piper Sandler observes that the shares are already priced for the ongoing Q4 decline. The firm forecasts that the company's growth may pick up speed in 2026 due to early indications of growth in emerging markets.
Piper Sandler stresses the corporation's lower dependency on the US market because of its involvement in emerging markets. The firm believes the company's price is attractive if growth occurs. Colgate-Palmolive Company has emerged as a dominant leader in the household and personal care industries. It is among the 7 Best Beauty Stocks to Buy Right Now.